Press Releases

WILMINGTON, Del., June 10, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today issued the following statement in response to the investor presentation released by Ancora Alternatives LLC: Ashland’s Board of Directors and management team are committed to driving sustainable value creation for all

WILMINGTON, Del., June 3, 2026, – Ashland, a global leader in specialty pharmaceutical excipients has announced the groundbreaking of a fourth Life Sciences’ aquarius™ film coatings manufacturing facility, located in Ambernath, Maharashtra, India. The new site is the company’s first tablet coatings

WILMINGTON, DE – May 19, 2026 – Ashland Inc. (NYSE: ASH) Ashland will unveil new Technology Platform innovations and ingredients at booth #1521 during NYSCC Suppliers’ Day 2026, May 19-20, 2026.

WILMINGTON, Del., May 18, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is announcing the appointment of Bertrand Loy to its board of directors, effective May 15, 2026. Loy currently serves as a director and the executive chair of Entegris Inc. (NASDAQ: ENTG), a leading supplier of advanced

WILMINGTON, Del., May 05, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock which represents a 1.2 percent increase from the previous quarter.

WILMINGTON, Del., May 4, 2026 — Ashland Inc. (NYSE: ASH), a long‑standing leader in architectural coatings additives, will showcase its expanded and growing solutions portfolio for industrial coatings during the American Coatings Show (ACS), May 5–7, 2026, Indianapolis, Ind., booth #1248.  

Sales of $482 million, up one percent from the prior-year quarter Income from continuing operations of $15 million, or $0.32 per diluted share Adjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $42 million, or $0.91 per diluted share Net income of $16 million,

WILMINGTON, Del., April 28, 2026, – Ashland announces an expanded, worldwide agreement with Wacker Chemie AG as the sole channel distribution partner for cyclodextrins as excipients in pharmaceuticals, including CAVAMAX*, CAVASOL* and Cavitron™.

WILMINGTON, Del., April 15, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its second-quarter fiscal 2026 earnings release at approximately 5 p.m. ET on Tuesday, April 28, 2026. The company’s live webcast with securities analysts will include an executive summary

WILMINGTON, DE – April 13, 2026 – Ashland Inc. (NYSE: ASH) today announces the launch of Eternight™ biofunctional, a novel Iris roots extract powered by PSR™ technology, guided by Ashland’s concept of Mitobiology™ and [3R] Longevity Science – Rest, Restore, Reverse.